Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-01 Sale |
2024-03-05 8:10 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer |
1,238 | $53.76 | $66,555 | 85,478 (Direct) |
View |
| 2024-03-01 Sale |
2024-03-05 8:08 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer |
4,768 | $53.76 | $256,328 | 101,363 (Direct) |
View |
| 2024-02-07 Sale |
2024-02-08 3:49 pm |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
30,000 | $45 | $1,350,000 | 2,803,755 (Indirect Direct) |
View |
| 2023-12-29 Sale |
2024-01-02 4:07 pm |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
30,000 | $47.87 | $1,436,100 | 2,833,755 (Indirect Direct) |
View |
| 2023-10-23 Sale |
2023-10-24 5:22 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP |
39,878 | $32.78 | $1,307,201 | 246,860 (Direct) |
View |
| 2023-10-19 Sale |
2023-10-23 5:14 pm |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
47,853 | $33.52 | $1,604,033 | 2,863,728 (Indirect Direct) |
View |
| 2023-09-07 Sale |
2023-09-11 1:52 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer |
2,163 | $40.8 | $88,249 | 26,614 (Direct) |
View |
| 2023-09-05 Sale |
2023-09-06 5:51 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer |
6,000 | $37.96 | $227,760 | 51,281 (Direct) |
View |
| 2023-09-01 Sale |
2023-09-06 5:50 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer |
970 | $37.15 | $36,032 | 23,777 (Direct) |
View |
| 2023-06-30 Sale |
2023-06-30 2:34 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Sanders Corazon (Corsee) D. Director |
585 | $46.76 | $27,355 | 8,985 (Direct) |
View |
| 2023-06-19 Sale |
2023-06-21 6:17 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer |
305 | $48.2 | $14,701 | 57,281 (Direct) |
View |
| 2023-06-07 Sale |
2023-06-09 2:32 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
3,300 | $51.82 | $171,006 | 34,165 (Direct) |
View |
| 2023-06-08 Sale |
2023-06-09 2:31 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Sanders Corazon (Corsee) D. Director |
1,485 | $51.65 | $76,700 | 16,680 (Direct) |
View |
| 2023-05-18 Sale |
2023-05-19 1:54 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks |
2,012 | $50 | $100,600 | 74,744 (Direct) |
View |
| 2023-05-04 Sale |
2023-05-05 2:16 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer |
4,378 | $45 | $197,010 | 51,982 (Direct) |
View |
| 2023-04-16 Sale |
2023-04-18 4:57 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer |
181 | $38.2 | $6,914 | 27,520 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-03 8:00 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
3,881 | $45.25 | $175,615 | 46,720 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-03 7:59 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer |
3,161 | $45.25 | $143,035 | 95,539 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-03 7:57 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP |
5,362 | $45.51 | $244,027 | 286,260 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-03 7:54 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer |
1,433 | $45.65 | $65,416 | 31,835 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-03 7:53 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks |
10,988 | $45.65 | $501,602 | 104,115 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-03 7:53 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks |
7,769 | $45.46 | $353,190 | 115,560 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-03 7:51 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer |
3,664 | $45.25 | $165,796 | 96,744 (Direct) |
View |
| 2023-02-28 Sale |
2023-03-02 2:28 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer |
639 | $43.4 | $27,733 | 15,558 (Direct) |
View |
| 2022-12-30 Sale |
2023-01-03 4:45 pm |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
19,582 | $45.57 | $892,352 | 2,824,385 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-01 Option Award |
2024-03-05 8:10 pm |
N/A 2034-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer |
55,951 | $0 | 85,478 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 8:08 pm |
N/A 2034-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer |
54,557 | $0 | 101,363 (Direct) |
View |
| 2024-03-01 Tax Withholding |
2024-03-05 8:06 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
17,417 | $53.69 | 2,897,992 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 8:06 pm |
N/A 2034-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
111,654 | $0 | 2,897,992 (Direct) |
View |
| 2024-01-02 Exercise |
2024-01-02 4:06 pm |
N/A 2024-01-29 |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer |
3,000 | $0 | 27,892 (Direct) |
View |
| 2024-01-02 Exercise |
2024-01-02 4:06 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer |
3,000 | $21 | 27,892 (Direct) |
View |
| 2023-12-20 Option Award |
2024-01-02 4:06 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer |
1,000 | $0 | 27,892 (Direct) |
View |
| 2023-10-23 Exercise |
2023-10-24 5:22 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP |
39,878 | $6.86 | 246,860 (Direct) |
View |
| 2023-10-23 Exercise |
2023-10-24 5:22 pm |
N/A 2023-10-31 |
Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP |
39,878 | $0 | 246,860 (Direct) |
View |
| 2023-10-19 Exercise |
2023-10-23 5:14 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
47,853 | $6.86 | 2,863,728 (Direct) |
View |
| 2023-10-19 Exercise |
2023-10-23 5:14 pm |
N/A 2023-11-01 |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
47,853 | $0 | 2,863,728 (Direct) |
View |
| 2023-10-09 Option Award |
2023-10-10 12:50 pm |
N/A 2033-10-09 |
Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer |
220,835 | $0 | 220,805 (Direct) |
View |
| 2023-09-27 Option Award |
2023-09-29 2:16 pm |
N/A 2027-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer |
2,351 | $0 | 25,965 (Direct) |
View |
| 2023-09-27 Option Award |
2023-09-29 2:15 pm |
N/A 2027-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer |
2,351 | $0 | 32,863 (Direct) |
View |
| 2023-09-07 Exercise |
2023-09-11 1:52 pm |
N/A 2024-01-29 |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer |
2,000 | $0 | 26,614 (Direct) |
View |
| 2023-09-07 Exercise |
2023-09-11 1:52 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer |
2,000 | $21 | 26,614 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 2:33 pm |
N/A 2033-06-07 |
Ultragenyx Pharmaceutical Inc. | RARE | Ray Amrit Director |
10,970 | $0 | 19,390 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 2:32 pm |
N/A 2033-06-07 |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
10,970 | $0 | 34,165 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 2:31 pm |
N/A 2033-06-07 |
Ultragenyx Pharmaceutical Inc. | RARE | Sanders Corazon (Corsee) D. Director |
10,970 | $0 | 16,680 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 2:30 pm |
N/A 2033-06-07 |
Ultragenyx Pharmaceutical Inc. | RARE | SULIMAN SHEHNAAZ Director |
10,970 | $0 | 21,965 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 2:30 pm |
N/A 2033-06-07 |
Ultragenyx Pharmaceutical Inc. | RARE | NARACHI MICHAEL Director |
10,970 | $0 | 28,715 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 2:29 pm |
N/A 2033-06-07 |
Ultragenyx Pharmaceutical Inc. | RARE | Dunsire Deborah Director |
10,970 | $0 | 26,840 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 2:28 pm |
N/A 2033-06-07 |
Ultragenyx Pharmaceutical Inc. | RARE | WELCH DANIEL G Director |
10,970 | $0 | 28,715 (Direct) |
View |
| 2023-05-09 Exercise |
2023-05-10 8:09 pm |
N/A 2024-01-29 |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer |
3,000 | $0 | 35,747 (Direct) |
View |
| 2023-05-09 Exercise |
2023-05-10 8:09 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer |
3,000 | $21 | 35,747 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-02 6:18 pm |
N/A 2033-05-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer |
13,020 | $0 | 38,874 (Direct) |
View |
Ownership |
2023-05-02 6:14 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer |
0 | $0 | 74,844 (Direct) |
View |
| 2023-04-16 Tax Withholding |
2023-04-18 4:57 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer |
14 | $38.2 | 27,520 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 8:00 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer |
2,663 | $0 | 46,720 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 7:59 pm |
N/A 2033-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer |
64,063 | $0 | 95,539 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 7:57 pm |
N/A 2033-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP |
64,063 | $0 | 286,260 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 7:54 pm |
N/A 2033-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer |
17,710 | $0 | 31,835 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 7:53 pm |
N/A 2033-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks |
64,063 | $0 | 104,115 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 7:53 pm |
N/A 2033-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks |
64,063 | $0 | 115,560 (Direct) |
View |
| 2023-03-01 Tax Withholding |
2023-03-03 7:52 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
16,140 | $45.65 | 2,946,661 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 7:52 pm |
N/A 2033-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
138,416 | $0 | 2,946,661 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 7:51 pm |
N/A 2033-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer |
64,063 | $0 | 96,744 (Direct) |
View |